GH Secretagogue Peptides
HGH-Frag 176-191
C₇₈H₁₂₃N₂₃O₂₃S₂
Key Research Findings
- Characterisation of the stabilised 176–191 fragment.
- Published in-vitro adipocyte lipolysis assay data.
- IGF-1-receptor non-binding profile reported in receptor-affinity studies.
Overview
HGH-Fragment 176–191 is a synthetic stabilised analogue of the C-terminal 176–191 sequence of human growth hormone. Supplied as a lyophilised powder for in-vitro research use only.
Mechanism of Action
Reported in published in-vitro adipocyte assays as a fragment active on lipolysis-related enzyme pathways without IGF-1-receptor binding. Not intended for human or veterinary use.
Research Effects
Adipocyte Lipolysis Assays
Extensive ResearchReported in in-vitro adipocyte cell-line assays as active on lipolysis-related enzyme pathways.
IGF-1 Receptor Profile
Moderate ResearchReceptor-affinity studies report no binding of IGF-1 receptor under assay conditions tested.
Chondrogenic Cell Studies
Preliminary ResearchEarly-stage in-vitro studies on chondrocyte cell models.
Research Purposes Only — All information on this page is provided for scientific research purposes only. This product is not intended for human consumption, diagnosis, treatment, or prevention of any disease.
Quick Facts
Research Status Key
Related Peptides
Cellular Peptides
AOD-9604
AOD-9604 is a synthetic modified fragment of the C-terminal sequence of human growth hormone (hGH 176–191). Supplied as a lyophilised powder for in-vitro research use only.
Learn More →
GH Secretagogue Peptides
CJC-1295 (No DAC)
CJC-1295 (No DAC) is a synthetic 29-residue analogue of growth-hormone-releasing hormone (GHRH), without the Drug Affinity Complex linker. Supplied as a lyophilised powder for in-vitro research use only.
Learn More →
GH Secretagogue Peptides
Ipamorelin
Ipamorelin is a synthetic pentapeptide ghrelin-receptor (GHSR-1a) agonist. Supplied as a lyophilised powder for in-vitro research use only.
Learn More →